Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management - Journal of Obstetrics and Gynaecology Canada

Frontiers Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father†

ACOG and local diagnostic criteria for hypertensive disorders of pregnancy (HDP) in La Paz-El Alto, Bolivia: A retrospective case-control study - The Lancet Regional Health – Americas

Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy - Canadian Journal of Cardiology

Pre-eclampsia - The Lancet

Determinants and Prevention of Low Birth Weight - Alberta Perinatal

Frontiers Hypertensive Disorders of Pregnancy and Subsequent Cardiovascular Disease: Current National and International Guidelines and the Need for Future Research

Hypertensive disorders of pregnancy

Implementation of a home blood pressure monitoring program for the management of hypertensive disorders of pregnancy, an observational study in British Columbia, Canada - Karen C Tran, Sabina Freiman, Tessa Chaworth-Musters, Susan

1-s2 - Artículo de investigación - SOGC CLINICAL PRACTICE GUIDELINE No. 426, May 2022 (Replaces No. - Studocu

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy - ScienceDirect

Pregnancy and COVID-19

Peripartum Cardiomyopathy: JACC State-of-the-Art Review

PDF] Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.

FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restriction - Melamed - 2021 - International Journal of Gynecology

Endostatin and Cystatin C as Potential Biomarkers for Early Prediction of Preeclampsia